CRSP Income Statement - CRISPR Therapeutics AG - Alpha Spread

CRISPR Therapeutics AG
NASDAQ:CRSP

Watchlist Manager
CRISPR Therapeutics AG Logo
CRISPR Therapeutics AG
NASDAQ:CRSP
Watchlist
Price: 46.4 USD -0.96%
Market Cap: 4B USD
Have any thoughts about
CRISPR Therapeutics AG?
Write Note

Income Statement

Earnings Waterfall
CRISPR Therapeutics AG

Revenue
202.2m USD
Operating Expenses
-556.9m USD
Operating Income
-354.7m USD
Other Expenses
88.8m USD
Net Income
-265.9m USD

Income Statement
CRISPR Therapeutics AG

Rotate your device to view
Income Statement
Currency: USD
Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024
Revenue
Revenue
0
N/A
1
+250%
2
+114%
3
+100%
5
+73%
7
+40%
10
+38%
11
+9%
41
+273%
40
-3%
37
-6%
35
-5%
3
-91%
2
-32%
1
-38%
213
+16 254%
290
+36%
289
0%
289
0%
77
-73%
1
-99%
1
+43%
902
+90 070%
902
+0%
915
+1%
915
+0%
15
-98%
14
-5%
1
-91%
100
+8 258%
170
+70%
170
0%
371
+118%
272
-27%
202
-26%
Operating Income
Operating Expenses
(26)
(34)
(48)
(58)
(73)
(85)
(92)
(102)
(106)
(111)
(124)
(148)
(162)
(183)
(199)
(222)
(243)
(268)
(293)
(313)
(355)
(396)
(454)
(491)
(541)
(603)
(649)
(701)
(674)
(662)
(644)
(594)
(594)
(570)
(557)
Selling, General & Administrative
(13)
(17)
(24)
(25)
(31)
(34)
(33)
(37)
(36)
(36)
(41)
(43)
(48)
(54)
(57)
(63)
(64)
(68)
(74)
(80)
(88)
(93)
(102)
(105)
(103)
(137)
(167)
(209)
(213)
(219)
(222)
(198)
(206)
(207)
(215)
Research & Development
(13)
(17)
(25)
(33)
(42)
(51)
(60)
(65)
(70)
(74)
(83)
(105)
(114)
(128)
(142)
(159)
(179)
(200)
(220)
(233)
(267)
(303)
(352)
(387)
(439)
(466)
(481)
(493)
(462)
(443)
(422)
(396)
(387)
(364)
(342)
Operating Income
(26)
N/A
(34)
-31%
(47)
-39%
(55)
-18%
(68)
-24%
(77)
-13%
(82)
-6%
(91)
-11%
(65)
+29%
(71)
-10%
(87)
-23%
(113)
-30%
(159)
-41%
(180)
-13%
(198)
-10%
(9)
+95%
47
N/A
22
-54%
(4)
N/A
(236)
-5 649%
(354)
-50%
(395)
-12%
448
N/A
412
-8%
374
-9%
312
-16%
(634)
N/A
(687)
-8%
(673)
+2%
(562)
+17%
(474)
+16%
(424)
+11%
(223)
+47%
(299)
-34%
(355)
-19%
Pre-Tax Income
Interest Income Expense
(0)
(8)
(9)
(9)
(45)
(37)
(37)
(37)
(2)
(3)
(3)
(4)
(4)
(4)
(4)
(6)
(6)
(4)
(3)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Non-Reccuring Items
0
12
12
12
12
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Total Other Income
0
(0)
0
(0)
79
79
78
78
(0)
(0)
0
0
(1)
0
2
5
26
29
28
25
6
4
4
5
6
5
7
13
23
35
50
63
72
84
92
Pre-Tax Income
(26)
N/A
(30)
-18%
(44)
-45%
(53)
-19%
(23)
+57%
(36)
-57%
(40)
-13%
(50)
-23%
(67)
-34%
(74)
-11%
(90)
-22%
(117)
-30%
(164)
-41%
(185)
-12%
(200)
-8%
(11)
+95%
67
N/A
46
-31%
21
-56%
(210)
N/A
(348)
-65%
(391)
-12%
451
N/A
416
-8%
380
-9%
317
-17%
(627)
N/A
(674)
-8%
(651)
+3%
(527)
+19%
(424)
+20%
(360)
+15%
(151)
+58%
(215)
-43%
(263)
-22%
Net Income
Tax Provision
0
(1)
(0)
(0)
(1)
(1)
(1)
(2)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(0)
(1)
(1)
(1)
(1)
(1)
(5)
(4)
(2)
(5)
(7)
(7)
0
3
8
7
(3)
(2)
(3)
Income from Continuing Operations
(26)
(31)
(44)
(53)
(23)
(36)
(41)
(51)
(68)
(75)
(91)
(117)
(165)
(185)
(200)
(11)
67
46
20
(211)
(349)
(392)
447
412
378
312
(633)
(681)
(650)
(524)
(416)
(354)
(154)
(217)
(266)
Income to Minority Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Net Income (Common)
(26)
N/A
(31)
-20%
(44)
-44%
(53)
-19%
(23)
+56%
(36)
-56%
(41)
-14%
(51)
-24%
(68)
-33%
(75)
-10%
(91)
-21%
(117)
-28%
(165)
-41%
(185)
-12%
(200)
-8%
(11)
+94%
67
N/A
46
-32%
20
-57%
(211)
N/A
(349)
-65%
(392)
-12%
447
N/A
412
-8%
378
-8%
312
-18%
(633)
N/A
(681)
-7%
(650)
+4%
(524)
+19%
(416)
+21%
(354)
+15%
(154)
+57%
(217)
-41%
(266)
-22%
EPS (Diluted)
-0.64
N/A
-0.77
-20%
-1.11
-44%
-1.32
-19%
-1.89
-43%
-0.91
+52%
-1.03
-13%
-1.28
-24%
-1.71
-34%
-1.63
+5%
-1.95
-20%
-2.47
-27%
-3.44
-39%
-3.55
-3%
-3.76
-6%
-0.19
+95%
1.17
N/A
0.75
-36%
0.31
-59%
-3.01
N/A
-5.29
-76%
-5.23
+1%
5.55
N/A
5.39
-3%
4.7
-13%
4.04
-14%
-8.17
N/A
-8.72
-7%
-8.36
+4%
-6.65
+20%
-5.25
+21%
-4.47
+15%
-1.94
+57%
-2.65
-37%
-3.13
-18%

See Also

Discover More